The protective effect of biologic and targeted-synthetic therapies on developing multisystem inflammatory syndrome in children
BackgroundMultisystem Inflammatory Syndrome in Children (MIS-C) is a severe, life threatening, complication that arises weeks after acute Coronavirus disease 2019 (COVID-19) infection, often presenting with fever and diverse systemic symptoms. Limited data exists on the effectiveness of biologic and...
Saved in:
| Main Authors: | Lana Khoury, Adi Miller-Barmak, Shereen Shehadeh, Hilla Cohen, Dana Hadar, Mohamad Hamad Saied |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pediatrics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2025.1607637/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Medical clown intervention shortens length of hospitalization in children with pneumonia
by: Lana Khoury, et al.
Published: (2025-06-01) -
Pediatric autoimmune diseases in the light of COVID-19 pandemic, A retrospective observational big data study
by: Rim Kasem Ali Sliman, et al.
Published: (2025-06-01) -
A Pediatric Case of Leptospirosis Developed after COVID-19 Associated Multisystem Inflammatory Syndrome
by: Kiana Razavi, et al.
Published: (2025-02-01) -
SARS CoV-2-Related Multisystem Inflammatory Syndrome in Adults: An Observational Case Series from Tropics
by: Sameer Gulati, et al.
Published: (2022-07-01) -
Multimodality cardiac evaluation in patients with Multisystem Inflammatory Syndrome in Children (MIS-C)
by: Hend Abu Shady, et al.
Published: (2025-07-01)